Radiotherapy with Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study
This journal activity provides practitioners with the knowledge in understanding whether radiotherapy when given with Cyclin-Dependent Kinase (CDK) 4/6 inhibitors is associated with a different toxicity profile than radiotherapy alone.
Category
- Breast Cancer
Format
- Journal SA-CME
Credits
- 1.00 Certificate of Attendance
- 1.00 SA-CME